A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD)
- Resource Type
- Article
- Source
- In
Leukemia Research 2008 32(3):421-427 - Subject
- Language
- ISSN
- 0145-2126